In vivo antioxidant status: A putative target of antidepressant action

被引:148
作者
Zafir, Ayesha [1 ]
Ara, Anjum [2 ]
Banu, Naheed [1 ]
机构
[1] Aligarh Muslim Univ, Dept Biochem, Fac Life Sci, Aligarh 202002, Uttar Pradesh, India
[2] Aligarh Muslim Univ, Dept Zool, Fac Life Sci, Aligarh 202002, Uttar Pradesh, India
关键词
Antidepressant; Antioxidant; Oxidative stress; Restraint stress; FORCED SWIMMING TEST; OXIDATIVE STRESS; ANIMAL-MODEL; SUPEROXIDE-DISMUTASE; MAJOR DEPRESSION; LIPID-PEROXIDATION; PREFRONTAL CORTEX; INDUCED ANHEDONIA; ENZYME-ACTIVITIES; VITAMIN-E;
D O I
10.1016/j.pnpbp.2008.11.010
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
Oxidative stress is a critical route of damage in various psychological stress-induced disorders, such as depression. Antidepressants are widely prescribed to treat these conditions; however, few animal studies have investigated the effect of these drugs on endogenous antioxidant status in the brain. The present study employed a 21-day chronic regimen of random exposure to restraint stress to induce oxidative stress in brain, and behavioural aberrations, in rodents. The forced swimming (FST) and sucrose preference tests were used to identify depression-like phenotypes, and reversal in these indices indicated the effectiveness of treatment with fluoxetine (FLU; 20 mg/kg/day, p.o.; selective serotonin reuptake inhibitor), imipramine (IMI; 10 mg/kg/day, p.o.; tricyclic antidepressant) and venlafaxine (VEN; 10 mg/kg/day, p.o.; dual serotonin/norepinephrine reuptake inhibitor) following restraint stress. The antioxidant status was investigated in the brain of these animals. The results evidenced a significant recovery in the activities of superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione reductase (GR) and glutathione (GSH) levels by antidepressant treatments following a restraint stress-induced decline of these parameters. The severely accumulated lipid peroxidation product malondialdehyde (MDA) and protein carbonyl contents in stressed animals were significantly normalized by antidepressant treatments. The altered oxidative status is implicated in various aspects of cellular function affecting the brain. Thus, it is possible that augmentation of in vivo antioxidant defenses could serve as a convergence point for multiple classes of antidepressants as an important mechanism underlying the neuroprotective pharmacological effects of these drugs observed clinically in the treatment of various stress disorders. Consequently, pharmacological modulation of stress-induced oxidative damage as a possible stress-management approach should be an important avenue of further research. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:220 / 228
页数:9
相关论文
共 80 条
[1]
AEBI H, 1984, METHOD ENZYMOL, V105, P121
[2]
Ca2+-independent caspase-3 but not Ca2+-dependent caspase-2 activation induced by oxidative stress leads to SH-SY5Y human neuroblastoma cell apoptosis [J].
Amoroso, S ;
D'Alessio, A ;
Sirabella, R ;
Di Renzo, G ;
Annunziato, L .
JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 68 (04) :454-462
[3]
Evaluation of a salivary based combined dexamethasone/CRH test in patients with major depression [J].
Baghai, TC ;
Schüle, C ;
Zwanzger, P ;
Minov, C ;
Holme, C ;
Padberg, F ;
Bidlingmaier, M ;
Strasburger, CJ ;
Rupprecht, R .
PSYCHONEUROENDOCRINOLOGY, 2002, 27 (03) :385-399
[4]
[5]
Antioxidative enzyme activities and lipid peroxidation in major depression:: alterations by antidepressant treatments [J].
Bilici, M ;
Efe, H ;
Köroglu, MA ;
Uydu, HA ;
Bekaroglu, M ;
Deger, O .
JOURNAL OF AFFECTIVE DISORDERS, 2001, 64 (01) :43-51
[6]
BORSINI F, 1988, PSYCHOPHARMACOLOGY, V94, P147
[7]
ELIMINATION OF ASCORBIC ACID-INDUCED MEMBRANE LIPID-PEROXIDATION AND SEROTONIN RECEPTOR LOSS BY TROLOX-C, A WATER-SOLUBLE ANALOG OF VITAMIN-E [J].
BRITT, SG ;
CHIU, VWS ;
REDPATH, GT ;
VANDENBERG, SR .
JOURNAL OF RECEPTOR RESEARCH, 1992, 12 (02) :181-200
[8]
Paradoxical effects of chronic corticosterone on forced swim behaviours in aged male and female rats [J].
Brotto, LA ;
Gorzalka, BB ;
Barr, AM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 424 (03) :203-209
[9]
Buege J A, 1978, Methods Enzymol, V52, P302
[10]
CARLBERG I, 1975, J BIOL CHEM, V250, P5475